IBERE PHARMACEUTICALS Inactive Instrument
Ibere Pharmaceuticals Share Price
Equities
IBER
KYG468431013
Investment Holding Companies
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Osagie Imasogie
CEO | Chief Executive Officer | 62 | - |
Lisa Gray
DFI | Director of Finance/CFO | 59 | - |
Zoltan Kerekes
COO | Chief Operating Officer | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Louis J. Vollmer
BRD | Director/Board Member | - | - |
Osagie Imasogie
CEO | Chief Executive Officer | 62 | - |
Elaine Jones
BRD | Director/Board Member | 69 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.11% | 66 M€ | +1.54% | - | |
| 0.37% | 15 M€ | -0.17% | - |
Ibere Pharmaceuticals is a blank check company. The Company is created for the purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company focuses on healthcare sector. The Company has no operations and has not generated revenues.
Sector
Investment Holding Companies
| 1st Jan change | Capi. | |
|---|---|---|
| +137.37% | 5.68B | |
| +1.89% | 1.01B | |
| +2.19% | 982M | |
| +41.91% | 872M | |
| +25.27% | 819M | |
| +1.68% | 663M | |
| +0.54% | 610M | |
| -.--% | 600M | |
| +21.31% | 552M |
